BALLY'S CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.96 USD | -0.29% |
|
-3.72% | +0.14% |
| Apr. 23 | Truist Raises Price Target on Bally's to $16 From $14, Keeps Buy Rating | MT |
| Apr. 15 | Trinity Health Files a Notice of Exempt Solicitation to Bally?s Corporation | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 878.1 | 1,531 | 2,069 | 915.9 | 636 | 564.4 | - | - |
| Enterprise Value (EV) 1 | 1,379 | 2,507 | 5,309 | 4,192 | 4,135 | 4,151 | 4,288 | 4,287 |
| P/E ratio | 17.6 x | -279 x | -26.2 x | -2.65 x | -4.3 x | -4.32 x | -5.77 x | -15.5 x |
| Yield | 0.78% | 0.2% | - | - | - | - | - | - |
| Capitalization / Revenue | 1.68 x | 4.11 x | 1.56 x | 0.41 x | 0.26 x | 0.22 x | 0.21 x | 0.2 x |
| EV / Revenue | 2.63 x | 6.73 x | 4.01 x | 1.86 x | 1.69 x | 1.61 x | 1.6 x | 1.51 x |
| EV / EBITDA | 8.25 x | 35.6 x | 15.9 x | 7.64 x | 7.84 x | 7.54 x | 7.04 x | 6.58 x |
| EV / FCF | 21.3 x | 594 x | -359 x | 71.4 x | -33.7 x | 51.8 x | 32.4 x | 35.5 x |
| FCF Yield | 4.69% | 0.17% | -0.28% | 1.4% | -2.97% | 1.93% | 3.09% | 2.81% |
| Price to Book | - | 4.72 x | 1.23 x | 1.12 x | 0.88 x | 1.31 x | 1.43 x | - |
| Nbr of stocks (in thousands) | 34,234 | 30,476 | 54,363 | 47,261 | 45,622 | 40,426 | - | - |
| Reference price 2 | 25.65 | 50.23 | 38.06 | 19.38 | 13.94 | 13.96 | 13.96 | 13.96 |
| Announcement Date | 3/3/20 | 3/4/21 | 2/24/22 | 2/23/23 | 2/21/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 523.6 | 372.8 | 1,322 | 2,256 | 2,449 | 2,581 | 2,678 | 2,847 |
| EBITDA 1 | 167.2 | 70.4 | 333.7 | 548.5 | 527.3 | 550.8 | 609.2 | 651.5 |
| EBIT 1 | 114.6 | 14.85 | 168.7 | 171 | 176.9 | 133.5 | 197.8 | 345.4 |
| Operating Margin | 21.89% | 3.98% | 12.76% | 7.58% | 7.22% | 5.17% | 7.39% | 12.13% |
| Earnings before Tax (EBT) 1 | 75.18 | -74.81 | -76.18 | -454.5 | -167.6 | -216.4 | -167.1 | -2.981 |
| Net income 1 | 55.13 | -5.487 | -71.8 | -425.5 | -172.6 | -159.5 | -117.8 | -42.98 |
| Net margin | 10.53% | -1.47% | -5.43% | -18.87% | -7.05% | -6.18% | -4.4% | -1.51% |
| EPS 2 | 1.460 | -0.1800 | -1.450 | -7.320 | -3.240 | -3.233 | -2.421 | -0.9022 |
| Free Cash Flow 1 | 64.65 | 4.219 | -14.77 | 58.72 | -122.9 | 80.16 | 132.3 | 120.6 |
| FCF margin | 12.35% | 1.13% | -1.12% | 2.6% | -5.02% | 3.11% | 4.94% | 4.24% |
| FCF Conversion (EBITDA) | 38.68% | 5.99% | - | 10.7% | - | 14.55% | 21.72% | 18.51% |
| FCF Conversion (Net income) | 117.26% | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.2000 | 0.1000 | - | - | - | - | - | - |
| Announcement Date | 3/3/20 | 3/4/21 | 2/24/22 | 2/23/23 | 2/21/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 314.8 | 547.7 | 548.3 | 552.5 | 578.2 | 576.7 | 598.7 | 606.2 | 632.5 | 611.7 | 627.3 | 646.2 | 664.4 | 642.3 | 662.2 |
| EBITDA 1 | 77.98 | 119.4 | 115 | 141.2 | 151 | 145.8 | 126.4 | 130 | 141.6 | 129.3 | 119.9 | 142.7 | 152.4 | 135.5 | 141.9 |
| EBIT 1 | 60.1 | 35.84 | 22.52 | 85.32 | 53.66 | 9.469 | 21.23 | 5.982 | 37.24 | 10.14 | 14.69 | 38.48 | 41.35 | 28.43 | 42.04 |
| Operating Margin | 19.09% | 6.54% | 4.11% | 15.44% | 9.28% | 1.64% | 3.55% | 0.99% | 5.89% | 1.66% | 2.34% | 5.95% | 6.22% | 4.43% | 6.35% |
| Earnings before Tax (EBT) 1 | -20.15 | -136.4 | -3.686 | 64.94 | 1.73 | -517.4 | 316.1 | -54.3 | -17.87 | -411.6 | -64.28 | -50.08 | -45.99 | -58.94 | -41.49 |
| Net income 1 | -14.75 | -115.3 | 1.889 | 59.5 | 0.593 | -487.5 | 178.3 | -25.65 | -61.8 | -263.5 | -54.65 | -35.06 | -30.88 | -42.34 | -38.34 |
| Net margin | -4.68% | -21.05% | 0.34% | 10.77% | 0.1% | -84.54% | 29.79% | -4.23% | -9.77% | -43.08% | -8.71% | -5.43% | -4.65% | -6.59% | -5.79% |
| EPS 2 | -0.3000 | -1.870 | 0.0300 | 0.9800 | 0.0100 | -8.870 | 3.240 | -0.4800 | - | -5.110 | -1.078 | -0.7151 | -0.5840 | -0.8400 | -0.8147 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/4/21 | 2/24/22 | 5/5/22 | 8/4/22 | 11/3/22 | 2/23/23 | 5/9/23 | 8/3/23 | 11/1/23 | 2/21/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 501 | 976 | 3,240 | 3,276 | 3,499 | 3,586 | 3,724 | 3,723 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 2.997 x | 13.87 x | 9.711 x | 5.973 x | 6.636 x | 6.511 x | 6.113 x | 5.714 x |
| Free Cash Flow 1 | 64.6 | 4.22 | -14.8 | 58.7 | -123 | 80.2 | 132 | 121 |
| ROE (net income / shareholders' equity) | - | -2.04% | 4.94% | -35.2% | -24% | 5.7% | 10.8% | - |
| ROA (Net income/ Total Assets) | - | - | - | - | -2.62% | -3.75% | -3.53% | - |
| Assets 1 | - | - | - | - | 6,581 | 4,248 | 3,332 | - |
| Book Value Per Share 2 | - | 10.60 | 30.80 | 17.30 | 15.90 | 10.60 | 9.780 | - |
| Cash Flow per Share 2 | - | 2.380 | - | 4.660 | 3.540 | 1.940 | 0.9200 | 6.240 |
| Capex 1 | 28.2 | 15.3 | 97.5 | 212 | 311 | 118 | 139 | 226 |
| Capex / Sales | 5.39% | 4.1% | 7.37% | 9.41% | 12.72% | 4.59% | 5.2% | 7.92% |
| Announcement Date | 3/3/20 | 3/4/21 | 2/24/22 | 2/23/23 | 2/21/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
13.96
USD
Average target price
11.95
USD
Spread / Average Target
-14.40%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.14% | 564M | |
| +7.14% | 33.01B | |
| +5.10% | 24.32B | |
| -18.63% | 19.87B | |
| -18.07% | 19.35B | |
| -1.52% | 16.62B | |
| -4.07% | 9.51B | |
| -21.91% | 7.92B | |
| +0.41% | 7.05B | |
| +6.70% | 7.13B |
- Stock Market
- Equities
- BALY Stock
- Financials Bally's Corporation
